Germany
· Delayed Price · Currency is EUR Sartorius Stedim Biotech Statistics
Total Valuation
ETR:56S1 has a market cap or net worth of EUR 16.82 billion. The enterprise value is 19.04 billion.
| Market Cap | 16.82B |
| Enterprise Value | 19.04B |
Important Dates
The next estimated earnings date is Wednesday, April 16, 2025.
| Earnings Date | Apr 16, 2025 |
| Ex-Dividend Date | Apr 2, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +5.01% |
| Shares Change (QoQ) | -0.91% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 27.74M |
Valuation Ratios
The trailing PE ratio is 96.08.
| PE Ratio | 96.08 |
| Forward PE | n/a |
| PS Ratio | 6.05 |
| PB Ratio | 4.18 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 35.39 |
| P/OCF Ratio | 20.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.43, with an EV/FCF ratio of 40.06.
| EV / Earnings | 108.74 |
| EV / Sales | 6.85 |
| EV / EBITDA | 29.43 |
| EV / EBIT | 49.15 |
| EV / FCF | 40.06 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.71.
| Current Ratio | 1.85 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 4.38 |
| Debt / FCF | 6.04 |
| Interest Coverage | 2.68 |
Financial Efficiency
Return on equity (ROE) is 5.33% and return on invested capital (ROIC) is 3.74%.
| Return on Equity (ROE) | 5.33% |
| Return on Assets (ROA) | 3.10% |
| Return on Invested Capital (ROIC) | 3.74% |
| Return on Capital Employed (ROCE) | 5.41% |
| Revenue Per Employee | 280,780 |
| Profits Per Employee | 17,685 |
| Employee Count | 9,901 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 2.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.46% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -34.46% |
| 50-Day Moving Average | 192.30 |
| 200-Day Moving Average | 184.78 |
| Relative Strength Index (RSI) | 41.00 |
| Average Volume (20 Days) | 18 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:56S1 had revenue of EUR 2.78 billion and earned 175.10 million in profits. Earnings per share was 1.81.
| Revenue | 2.78B |
| Gross Profit | 1.21B |
| Operating Income | 396.00M |
| Pretax Income | 219.20M |
| Net Income | 175.10M |
| EBITDA | 629.30M |
| EBIT | 396.00M |
| Earnings Per Share (EPS) | 1.81 |
Balance Sheet
The company has 688.80 million in cash and 2.87 billion in debt, giving a net cash position of -2.18 billion.
| Cash & Cash Equivalents | 688.80M |
| Total Debt | 2.87B |
| Net Cash | -2.18B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.02B |
| Book Value Per Share | 40.97 |
| Working Capital | 802.20M |
Cash Flow
In the last 12 months, operating cash flow was 815.10 million and capital expenditures -339.80 million, giving a free cash flow of 475.30 million.
| Operating Cash Flow | 815.10M |
| Capital Expenditures | -339.80M |
| Free Cash Flow | 475.30M |
| FCF Per Share | n/a |
Margins
Gross margin is 43.41%, with operating and profit margins of 14.24% and 6.30%.
| Gross Margin | 43.41% |
| Operating Margin | 14.24% |
| Pretax Margin | 7.88% |
| Profit Margin | 6.30% |
| EBITDA Margin | 22.64% |
| EBIT Margin | 14.24% |
| FCF Margin | 17.10% |
Dividends & Yields
This stock pays an annual dividend of 0.69, which amounts to a dividend yield of 0.44%.
| Dividend Per Share | 0.69 |
| Dividend Yield | 0.44% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 38.32% |
| Buyback Yield | -5.01% |
| Shareholder Yield | -4.57% |
| Earnings Yield | 1.04% |
| FCF Yield | 2.83% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ETR:56S1 has an Altman Z-Score of 3.8.
| Altman Z-Score | 3.8 |
| Piotroski F-Score | n/a |